Journal of Medicinal Chemistry p. 2591 - 2600 (1992)
Update date:2022-08-04
Topics:
Lowe, John A.
Drozda, Suzan E.
Snider, R. Michael
Longo, Kelly P.
Zorn, Stevin H.
et al.
We describe the structure-activity relationship development of a series of quinuclidines which culminated in the first potent, selective, nonpeptide substance P (SP) antagonist, (2S,3S)-cis-2-(diphenylmethyl)-N-<(2-methoxyphenyl)methyl>-1-azabicyclo<2.2.2
View MoreSHANDONG QINGYUNCHANGXIN CHEMICAL SCIENCE-TECH CO.,LTD
Contact:86-21-60560171
Address:1689Donghuan Rade,Qingyun County, Dezhou City, Shandong,China
Ningbo Distant Chemicals Co.,Ltd
Contact:86-574-27862490,27862438
Address:5F-3,#54 DaShaNi street,Ningbo,CHINA
Changsha Goomoo Chemical Technology Co.Ltd
Contact:+86-731-82197655
Address:No.649,Chezhan Rd.(N),Changsha,Hunan,China
Anqing World Chemical Co., Ltd.
Contact:+86-556-5800026
Address:Daguan Economic Development Zone of circular economy industrial park Anqing City Anhui province
Chengdu Push Bio-technology Co., Ltd
Contact:86-28-85370565
Address:No.8 Wuke West Second Road, Wuhou
Doi:10.1021/ja00975a028
(1966)Doi:10.1016/S0040-4039(00)78885-X
(1992)Doi:10.1021/ol303546p
(2013)Doi:10.1039/c2ob27221k
(2013)Doi:10.1021/ml300321d
(2013)Doi:10.1039/c2ce25841b
(2012)